CEO: | Markku Jalkanen |
Independent Non-Executive Director: | John Poulos |
Non-Executive Chairman: | Frank Armstrong |
Non-Executive Dir: | Arthur J Roth, Erik Ostrowski, Tuomo Pätsi, Marie-Louise Fjällskog |
Address: | Joukahaisenkatu 6, Turku, Finland, FI-20520 |
Phone: | +358 2 469 5151 |
Fax: | +358 2 469 5152 |
Website: | http://www.faronpharmaceuticals.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | FI4000153309 |
Currency | UK Pounds |
Share Price | 137.50p |
Change Today | -2.50p |
% Change | -1.79 % |
52 Week High | 350.00 |
52 Week Low | 125.00 |
Volume | 40,251 |
Shares Issued | 68.81m |
Market Cap | £94.61m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 1 |
Strong Sell | 1 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
14:16 | 10 @ 135.00p |
14:16 | 208 @ 140.00p |
14:16 | 54 @ 135.00p |
11:46 | 25,000 @ 137.59p |
13:20 | 7 @ 137.00p |
You are here: research